On Feb 11, 2025, the Global Platform for Access to Childhood Cancer Medicines (known as the Global Platform) announced that it had started distributing drugs to the six countries participating in the pilot phase of the initiative. The platform is a partnership between WHO and St Jude Children’s Research Hospital, which is providing technical support and US$200 million in funding. The short-term goal is to deliver enough quality-assured paediatric cancer medication to treat some 120 000 children in 50 or so low-income and middle-income countries (LMICs) within the next 5–7 years.